Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"Alimentary pharmacology & therapeutics"
topic_facet:"9008-11-1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22&filter%5B%5D=topic_facet%3A%229008-11-1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22antiviral%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22&filter%5B%5D=topic_facet%3A%229008-11-1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22antiviral%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Alimentary+pharmacology+%26+therapeutics%22&filter%5B%5D=topic_facet%3A%229008-11-1%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22antiviral%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (84)
1
Editorial : pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Jachs, M.
|
Reiberger, T.
|
Ferenci, P.
CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. - PMID 35514008
Wird geladen...
2
Editorial : tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Peng, C.
CommentOn: Aliment Pharmacol Ther. 2022 Sep;56(5):878-889. - PMID 35872575
Wird geladen...
3
Editorial : tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B. Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Luo, M.
|
Jiang, D.
CommentOn: Aliment Pharmacol Ther. 2022 Sep;56(5):878-889. - PMID 35872575
Wird geladen...
4
Editorial : hepatocellular carcinoma risk prediction models following DAA-mediated SVR-more evidence needed
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Romero, S.
|
Holmes, J.
CommentOn: Aliment Pharmacol Ther. 2021 Nov;54(10):1340-1349. - PMID 34618934
Wird geladen...
5
Letter : contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Shao, S.
|
Lai, E.
|
Chang, K.
| +3
CommentOn: Aliment Pharmacol Ther. 2018 Dec;48(11-12):1290-1300. - PMID 30362139
Wird geladen...
6
Letter : contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Liu, C.
|
Kao, J.
CommentOn: Aliment Pharmacol Ther. 2018 Dec;48(11-12):1290-1300. - PMID 30362139
Wird geladen...
7
Editorial : identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Liem, K.
|
Janssen, H.
CommentOn: Aliment Pharmacol Ther. 2019 Mar;49(5):609-610. - PMID 30746775
Wird geladen...
8
Editorial : identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Peng, C.
CommentOn: Aliment Pharmacol Ther. 2019 Feb;49(4):448-456. - PMID 30689258
Wird geladen...
9
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Li, J.
|
Gordon, S.
|
Rupp, L.
| +22
CommentIn: Aliment Pharmacol Ther. 2019 Apr;49(8):1094-1095. - PMID 30920046
Wird geladen...
10
Editorial : comorbidities, concomitant medications, and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C
enthalten in:
Alimentary pharmacology & therapeutics
| 2019
von
Kawabe, N.
|
Hashimoto, S.
|
Yoshioka, K.
CommentOn: Aliment Pharmacol Ther. 2018 Dec;48(11-12):1290-1300. - PMID 30362139
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Alimentary pharmacology & therapeutics
Filter aufheben
Thema: 9008-11-1
Medienart
84
Aufsätze
69
E-Artikel
69
E-Ressourcen
15
Gedruckte Aufsätze
Zeitschriftentitel
Alimentary pharmacology & therapeutics
Thema
9008-11-1
84
Antiviral Agents
84
Interferons
55
Journal Article
43
49717AWG6K
43
Ribavirin
33
Research Support, Non-U.S. Gov't
29
Comment
24
Review
16
Interleukins
15
Letter
14
Editorial
13
Interferon-alpha
13
Systematic Review
13
interferon-lambda, human
12
3WJQ0SDW1A
12
Polyethylene Glycols
12
Recombinant Proteins
11
Meta-Analysis
10
Hepatitis B e Antigens
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
61
2010-2019
19
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
84
Englisch
Haven't found what you're looking for?
Wird geladen...